Patients' and clinicians' perspectives on telemedicine to monitor patients on systemic treatment for psoriasis or atopic dermatitis - a mixed methods study

BACKGROUND: For patients with stable psoriasis or atopic dermatitis (AD) receiving systemic treatment, telemedicine may offer a viable alternative to in-person consultations. However, perspectives of these patients and dermatological care providers (DCPs) regarding telemedicine are underexplored, yet essential for successful implementation.

OBJECTIVES: To explore experiences, preferences, and perspectives of patients and DCPs regarding telemedicine for patients with psoriasis or AD on systemic treatment.

METHODS: A mixed-methods study was conducted using surveys and semi-structured interviews with patients and DCPs.

RESULTS: Surveys were completed by 162 patients and 152 DCPs, and interviews by 12 patients and 5 DCPs. Both groups expressed positive attitudes toward telemedicine, provided stable disease. Patients valued telemedicine for practical benefits, including time/cost savings, but emphasized the importance of an established relationship with DCPs before its initiation. DCPs identified key enablers including improved ICT-support, user-friendly systems, and adequate reimbursement. The majority of patients and DCPs supported telemedicine implementation, with telephonic consultations as preferred method. Many DCPs believed ≥50% of consultations could be conducted through telemedicine. Additionally, telemedicine leads to substantial CO2-equivalent emission reduction.

CONCLUSION: Patients and DCPs supported further implementation of telemedicine in patients with stable psoriasis or AD on systemic treatment and identified practical, financial and societal facilitators.